HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

An analysis of myeloma plasma cell phenotype using antibodies defined at the IIIrd International Workshop on Human Leucocyte Differentiation Antigens.

Abstract
Fresh bone marrow from 43 cases of myeloma and three cases of plasma cell leukaemia has been phenotyped both by indirect immune-rosetting and, on fixed cytospin preparations, by indirect immunofluorescence. Both clustered and unclustered B cell associated antibodies from the IIIrd International Workshop on Human Leucocyte Differentiation Antigens were used. The results confirm the lack of many pan-B antigens on the surface of myeloma plasma cells, i.e. CD19-23, 37, 39, w40. Strong surface reactivity is seen with CD38 antibodies and with one CD24 antibody (HB8). Weak reactions are sometimes obtained with CD9, 10 and 45R. On cytospin preparations CD37, 39 and w40 are sometimes weakly positive, and anti-rough endoplasmic reticulum antibodies are always strongly positive. Specific and surface-reacting antiplasma cell antibodies are still lacking.
AuthorsN Jackson, N R Ling, J Ball, E Bromidge, P D Nathan, I M Franklin
JournalClinical and experimental immunology (Clin Exp Immunol) Vol. 72 Issue 3 Pg. 351-6 (Jun 1988) ISSN: 0009-9104 [Print] England
PMID3048803 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Monoclonal
  • Antigens, Differentiation, T-Lymphocyte
  • Antigens, Neoplasm
  • Antigens, Surface
Topics
  • Antibodies, Monoclonal
  • Antigens, Differentiation, T-Lymphocyte (analysis)
  • Antigens, Neoplasm (analysis)
  • Antigens, Surface (analysis)
  • Cytoplasm (immunology)
  • Fluorescent Antibody Technique
  • Humans
  • Leukemia, Plasma Cell (immunology)
  • Multiple Myeloma (immunology)
  • Rosette Formation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: